PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.30%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.22%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
15.97%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
15.09%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
-6.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2.56%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.63%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.73%
Share count expansion well above QCOM's 0.53%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
17.08%
Slight or no buyback while QCOM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
4.95%
Dividend growth of 4.95% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
34.22%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-197.20%
Negative FCF growth while QCOM is at 2.81%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
29.76%
10Y revenue/share CAGR under 50% of QCOM's 2269.46%. Michael Burry would suspect a lasting competitive disadvantage.
-26.65%
Negative 5Y CAGR while QCOM stands at 254.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.01%
Positive 3Y CAGR while QCOM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-2.10%
Negative 10Y OCF/share CAGR while QCOM stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
7.60%
Below 50% of QCOM's 795.23%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
24.27%
3Y OCF/share CAGR under 50% of QCOM's 142.88%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
953.20%
10Y net income/share CAGR of 953.20% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
90.10%
Below 50% of QCOM's 761.61%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
299.75%
3Y net income/share CAGR 1.25-1.5x QCOM's 266.16%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
302.95%
Below 50% of QCOM's 26346.39%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
168.64%
Below 50% of QCOM's 367.21%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
91.42%
Below 50% of QCOM's 328.33%. Michael Burry suspects a serious short-term disadvantage in building book value.
21.42%
Dividend/share CAGR of 21.42% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-2.02%
Negative 5Y dividend/share CAGR while QCOM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-2.13%
Negative near-term dividend growth while QCOM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.69%
Firm’s AR is declining while QCOM shows 1.19%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.89%
Inventory growth well above QCOM's 15.44%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.38%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.45%
Positive BV/share change while QCOM is negative. John Neff sees a clear edge over a competitor losing equity.
-3.74%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-17.26%
Our R&D shrinks while QCOM invests at 6.16%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.48%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.